A cluster of meningococcal disease in a university hall of residence
A university town of 180,000 people reports three cases of invasive meningococcal disease (IMD) in 11 days, all in first-year undergraduates living in the same 400-bed hall of residence. Case A (18 years) presented with fever, neck stiffness and a non-blanching rash; blood PCR was Neisseria meningitidis group B. Case B (19 years) had rapid-onset septic shock and died within 12 hours; PCR from blood was group B. Case C (18 years) had milder symptoms and was confirmed as group W. All three had shared a crowded bar on the same weekend, and Cases A and B shared a kitchen. The local health protection team must decide on prophylaxis and wider action. The hall has one shared kitchen per 20 students, and 60 residents are unvaccinated against MenACWY.
1. Define whether this is a cluster, an outbreak, or an incident, and justify the public health action threshold you would apply.
Read the worked answer
Assessment. Three cases in 11 days in a defined closed-ish setting exceeds the expected background for a town of this size (national IMD incidence is roughly 1–3 per 100,000 per year; expected cases in 180,000 over 11 days is a fraction of one). This meets the practical definition of a cluster - cases linked in person, place and time more than expected - and, because two are group B in the same hall, it is best managed as an outbreak for operational purposes.
Key nuance. Case C is a different serogroup (W), so it is microbiologically a separate event. It should not be counted as part of a single-strain outbreak, but it does not reduce concern: it signals low population immunity and possible wider transmission.
Action threshold. Do not wait for a formal statistical threshold. The trigger for public health action is two or more cases of the same serogroup in a defined setting within a short interval, which mandates urgent risk assessment, contact tracing and chemoprophylaxis. The group W case triggers a separate assessment and a vaccination review.
Judgement call. The exam wants you to separate the epidemiological question (is this more than expected?) from the microbiological question (is this one strain?). Both matter, and they lead to different actions.
2. Who should receive chemoprophylaxis, and what would you do about the 60 unvaccinated residents and the wider student population?
Read the worked answer
Chemoprophylaxis (for the group B cluster). Give antibiotic prophylaxis (typically ciprofloxacin 500 mg single dose, or rifampicin where ciprofloxacin is contraindicated) to close contacts of Cases A and B:
- household/hall-flat contacts who share a kitchen or bathroom;
- anyone who has had intimate or prolonged close contact in the 7 days before onset;
- healthcare workers with direct exposure to respiratory secretions (e.g. during intubation) without PPE.
Not indicated: casual contacts, people in the same lectures, or the whole hall. Blanket prophylaxis of 400 residents is not justified and risks resistance and adverse events.
Group W case. Prophylaxis for close contacts of Case C, and assess whether a MenACWY vaccination campaign is warranted.
Vaccination. The 60 unvaccinated residents should be offered MenACWY urgently; this protects against W (and A, C, Y) but not B. For group B, use a MenB vaccine if available and consider a targeted campaign for the hall.
Wider action. Notify the university, issue public health messaging about symptoms (fever, rash, neck stiffness, drowsiness), and ensure rapid access to assessment. Do not close the hall - closure is not an effective control and causes harm.
3. The university asks you to close the hall for two weeks to 'stop the spread'. How do you respond, and what communication risks do you anticipate?
Read the worked answer
Recommendation: do not close the hall. Closure is not an effective control measure for IMD because:
- transmission requires close/prolonged contact, not airborne spread in corridors;
- cases may already have occurred before symptoms, so closure does not interrupt transmission;
- it displaces students into new mixing patterns and can delay presentation;
- it causes significant educational, financial and psychological harm.
What to do instead. Intensify case-finding, ensure rapid access to care, deliver prophylaxis and vaccination, and communicate clearly.
Communication risks.
- Over-reassurance vs alarm: saying 'low risk' while doing mass prophylaxis looks inconsistent; explain why targeted action is proportionate.
- Stigma: naming the hall or nationality of cases can stigmatise; avoid identifying details.
- Vaccine confusion: students may believe MenACWY protects against group B; be explicit.
- Misinformation: social media rumours about 'killer meningitis' need a single trusted source and regular updates.
Governance. Document the risk assessment, the rationale for not closing, and the review date. Offer the university a written statement they can share.